Abbvie Inc
BMV:ABBV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Abbvie Inc
BMV:ABBV
|
US |
|
E
|
Empresa Distribuidora y Comercializadora Norte SA
F:PWD1
|
AR |
|
V
|
Verizon Communications Inc
XBER:BAC
|
US |
|
C
|
Canopy Growth Corp
F:11L1
|
CA |
|
V
|
Vinci SA
XMUN:SQU
|
FR |
|
P
|
Pfizer Inc
XBER:PFE
|
US |
|
Young & Co's Brewery PLC
F:YBY
|
UK |
|
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
|
IL |
|
Cigna Corp
NYSE:CI
|
US |
|
F
|
Factset Research Systems Inc
DUS:FA1
|
US |
|
Great Elm Capital Corp
NASDAQ:GECC
|
US |
|
U
|
US Foods Holding Corp
F:UFH
|
US |
|
BlackRock Inc
MIL:1BLK
|
US |
|
U
|
Universal Health Services Inc
F:UHS
|
US |
|
E
|
Erlebnis Akademie AG
F:EAD
|
DE |
Wall St Price Targets
ABBV Price Targets Summary
Abbvie Inc
According to Wall Street analysts, the average 1-year price target for ABBV is 4 398.9 MXN with a low forecast of 3 253.98 MXN and a high forecast of 5 905.77 MXN.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ABBV's stock price target?
Price Target
4 398.9
MXN
According to Wall Street analysts, the average 1-year price target for ABBV is 4 398.9 MXN with a low forecast of 3 253.98 MXN and a high forecast of 5 905.77 MXN.
What is the Revenue forecast for Abbvie Inc?
Projected CAGR
5%
Over the last 14 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Abbvie Inc?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 8 years is 11%.
What is the Net Income forecast for Abbvie Inc?
Projected CAGR
32%
Over the last 14 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 8 years is 32%.
